To provide the potential for reliable growth by tracking the performance of the FTSE 100 Index.
Name | % Net Assets |
---|---|
BP PLC | 8.1% |
HSBC Holdings PLC | 7.7% |
Vodafone Group PLC | 5.5% |
GlaxoSmithKline PLC | 5.0% |
Royal Dutch Shell PLC | 4.8% |
Royal Dutch Shell PLC B | 3.7% |
AstraZeneca PLC | 3.5% |
BG Group PLC | 3.1% |
British American Tobacco PLC | 3.0% |
BHP Billiton PLC | 2.7% |
Key | % Net Assets |
---|---|
BP PLC | 8.1% |
HSBC Holdings PLC | 7.7% |
Vodafone Group PLC | 5.5% |
GlaxoSmithKline PLC | 5.0% |
Other | 73.7% |
Date | 02-Nov-2018 |
---|---|
Bid | 180.90p |
Offer | 180.90p |
Currency | GBP |
Change | 1.00p |
% | 0.56% |
YTD change | 180.90p |
YTD % | n/a |
Fund Inception | 28/05/1993 |
---|---|
Fund Manager | Ian Clarke |
TER | - |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.90% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.06 |
You are here: research